Chest physiotherapy is a critical component of respiratory care aimed at improving airway clearance, enhancing lung function, and preventing complications in patients with various pulmonary conditions. This therapeutic approach employs a combination of manual techniques, postural drainage, percussion, vibration, and breathing exercises to mobilize mucus and secretions from the airways, facilitating their removal. Chest physiotherapy is particularly beneficial for individuals with chronic respiratory diseases, such as cystic fibrosis, bronchiectasis, chronic obstructive pulmonary disease, and pneumonia, as well as patients recovering from surgery or prolonged mechanical ventilation. Implementation requires a thorough assessment of the patient’s lung status, airway obstruction patterns, and overall health to tailor interventions effectively. Collaboration between physiotherapists, pulmonologists, and nursing staff ensures safe and coordinated care, optimizing both efficacy and patient comfort. Education and active participation of patients or caregivers in performing techniques at home enhance long-term outcomes, including reduced frequency of infections, improved oxygenation, and increased exercise tolerance. Advances in technology, such as mechanical devices that simulate manual techniques, have expanded the accessibility and consistency of therapy. Evidence indicates that consistent application of chest physiotherapy not only aids in symptom relief but also contributes to better quality of life and reduced hospitalizations. By combining skilled techniques, patient engagement, and individualized care plans, chest physiotherapy supports airway health, promotes respiratory efficiency, and strengthens overall lung function in both acute and chronic respiratory conditions.
Title : Screening questionnaires for obstructive sleep apnea: An updated systematic review
Behzad Rahmati, Isfahan University of Medical Sciences, Iran (Islamic Republic of)
Title : Improving covid 19 candidate vaccine response through probiotics and micronutrient supplementation: Evaluating the role of TLR5
Zohre Eftekhari, Biotechnology Research Center, Pasteur Institute of Iran, Iran (Islamic Republic of)
Title : Novel signaling mechanisms and innovative therapeutic strategies of pulmonary hypertension
Yong Xiao Wang, Albany Medical College, United States
Title : Iatrogenic pneumothorax following nephrectomy: Case report
Chaimae Tahiri, National University Hospital Center of Fann, Senegal